Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Use of Antiemetic Agents in Acute Gastroenteritis 3. 2008 Exclusive Survey—Earnings: Good news for primary care income 4. A randomised phase III study on capecitabine, oxaliplatin and bevacizumab with or without cetuximab in first-line advanced colorectal cancer, the CAIRO2 study of the Dutch Colorectal Cancer Group (DCCG). An interim analysis of toxicity 5. Medicare pay-for-reporting effort draws fire from frustrated doctors
Your Article Summary
See Latest ArticlesRecurrent Clostridium difficile infection: A review of risk factors, treatments, and outcomes
Journal of Infection, 06/10/09
Johnson S et al. - Current guidelines recommend that the first recurrent episode be treated with the same agent (i.e., metronidazole or vancomycin) used for the index episode. A reasonable strategy for managing a subsequent episode involves tapering followed by pulsed doses of vancomycin. Other potentially effective strategies for recurrent CDI include vancomycin with adjunctive treatments, such as Saccharomyces boulardii, rifaximin “chaser” therapy after vancomycin, nitazoxanide, fecal transplantation, and intravenous immunoglobulin. New treatment agents that are active against C. difficile, but spare critical components of the normal flora, may decrease the incidence of recurrent CDI.
Related Articles
Toxigenic Clostridium difficile colonization in children
Journal of Pediatric Infectious Diseases, 10/30/09
Relevance Score: 68%
Molecular Epidemiology of Clostridium difficile over the Course of 10 Years in a Tertiary Care Hospital
Clinical Infectious Diseases, 10/16/09
Relevance Score: 67%
Clostridium difficile-related death rates in Texas 1999-2005
Journal of Infection, 10/06/09
Relevance Score: 67%
Bacteriophage-Mediated Toxin Gene Regulation in Clostridium difficile
Journal of Virology, 11/09/09
Relevance Score: 66%
Use of International Classification of Diseases, Ninth Revision, Clinical Modification Codes and Medication Use Data to Identify Nosocomial Clostridium difficile Infection
Infection Control and Hospital Epidemiology, 10/14/09
Relevance Score: 66%
Today in GI Infectious Disease...keeping you current
Receive free subspecialty "5-minute updates" via email
Small Intestinal Bacterial Overgrowth in Irritable Bowel Syndrome: Systematic Review and Meta-analysis
Clinical Gastroenterology and Hepatology , 12/10/09
Helicobacter species in the human colon
Colorectal Disease, 12/10/09
Pathology of non-Helicobacter pylori gastritis: extending the histopathologic horizons
Journal of Gastroenterology, 12/10/09
Today in Pharmacology/kinetics...keeping you current
Receive free subspecialty "5-minute updates" via email
Inhibitory effect of emodin and Astragalus polysaccharide on the replication of HBV
World Journal of Gastroenterology, 12/10/09
Chemoprevention in Barrett's Esophagus: Are We There Yet, Are We There Yet...
Clinical Gastroenterology and Hepatology , 12/10/09
Cause for controversy? Infliximab in the treatment of ulcerative colitis: an update
Clinical and Experimental Gastroenterology, 12/10/09
Sponsor
Article Search
Sponsor
Sponsor